/ /

Cheryl Guttman Krader
Reading performance highlights functional impact of glaucoma
Reading speed is reduced in patients with glaucomatous visual field loss and normal visual acuity, and the reduction in performance is directly proportional to the extent of the visual field loss, said Aron Guimaraes, MD.
DMEK outcomes favorable after mid-term duration of follow-up
Findings from a mid-term evaluation of the first Descemet Membrane Endothelial Keratoplasty (DMEK) cohort show that the procedure results in a near complete visual recovery that is achieved at 6 months and seems to remain stable for at least up to 6 years, said Fook Chang Lam, MD.
Acupuncture an alternative for treatment-refractory dry eye
A targeted approach to treatment based on the findings of a thorough history, appropriate testing, and clinical exam can be successful for bringing relief to many patients with dry eye that is difficult to manage, said Deepinder K. Dhaliwal, MD.
Role of anti-VEGF for cornea, ocular surface disease still emerging
Evidence for assessing the efficacy and safety of anti-vascular endothelial growth factor (VEGF) agents for treating corneal and ocular surface disease is accumulating. However, there is clearly a need for more research to define if, when, and how this therapy should be used, said Anat Galor, MD.
Closing cataract incisions: Sealant superior to sutures
A hydrogel sealant demonstrated significant superiority to suturing for sealing incisions that were leaking when tested immediately after small-incision phacoemulsification and toric IOL implantation.
Hydrogel corneal inlay studied as 'valuable' tool for presbyopic
Outcomes from up to 12 months of follow-up in a prospective case series including 25 patients show promising results using the transparent, hydrogel corneal inlay for correction of presbyopia.
Novel microshunt providing dramatic and stable IOP control
An investigational glaucoma device that shunts aqueous from the anterior chamber to a sub-conjunctival/sub-Tenon’s pouch is being evaluated in a prospective study of 35 eyes operated on at two centers.
In control: Unfolding a monofocal lens
A single-piece hydrophobic acrylic IOL has many features that make it a good choice for a monofocal implant in routine and challenging cataract surgery cases.
Integrin peptide therapy promising as novel DME treatment
Extensive studies in animals and initial experience in human trials support interest in integrin peptide therapy as an emerging new class of treatment for vascular eye disease, according to Baruch Kuppermann, MD, PhD.
More crowded anterior segment likely in Chinese eyes
Ethnic differences in anterior chamber angle anatomy exist and may explain the increased risk for angle-closure glaucoma among Chinese, said Shan C. Lin, MD, professor of ophthalmology and co-director of the glaucoma service, University of California San Francisco School of Medicine.


View Results